Radiation Oncology/Therapy: Page 229

Varian reports 1st motion review use
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems said that the University of Alabama at Birmingham Health System is the first medical center in the world to utilize its intrafraction motion review technology to continuously monitor tumor location during radiosurgery for lung cancer.
November 21, 2011
RaySearch adds South Korean distributor
By AuntMinnie.com staff writers
Radiation therapy firm RaySearch Laboratories has signed an exclusive distribution agreement with Oncology Total Solution of Seoul, South Korea.
November 20, 2011
Probiotic protects intestines in mice from radiation injury
By Cynthia E. Keen
Scientists at Washington University School of Medicine in St. Louis have shown that ingesting probiotic bacteria before undergoing radiation therapy can protect healthy tissue in the intestine from radiation.
November 17, 2011
RTOG launches prostate cancer RT trial
By AuntMinnie.com staff writers
The Radiation Therapy Oncology Group (RTOG) has launched a clinical trial to investigate the quality-of-life effects for prostate cancer patients who receive higher doses of radiation in fewer treatments.
November 16, 2011
Manhattan Isotope inks cyclotron agreement
By AuntMinnie.com staff writers
Manhattan Isotope Technology, with the support of molecular imaging developer Positron, has signed a memorandum of understanding with the ARRONAX cyclotron facility in Nantes, France, that will allow the firms to collaborate on the production of strontium-82 and other medical radionuclides.
November 16, 2011
AccuBoost nets radiotherapy order
By AuntMinnie.com staff writers
Women's health firm AccuBoost has received an order from radiation therapy provider RADM in Florida.
November 15, 2011
Radiation dose still high on ECRI's technology hazards list
By Cynthia E. Keen
Inappropriate and/or unnecessary radiation dose exposure from CT scans and radiation therapy is still in the top 10 list of health technology hazards published annually by research and consulting group ECRI Institute.
November 15, 2011
Landauer buys IZI Medical Products
By AuntMinnie.com staff writers
Radiation monitoring firm Landauer announced it has acquired IZI Medical Products of Baltimore for approximately $93 million.
November 14, 2011
IsoRay's sales dip slightly in Q1
By AuntMinnie.com staff writers
A temporary one-month reduction of orders for prostate applications in July adversely affected product sales for medical isotope developer IsoRay Medical in the first quarter of fiscal year 2011.
November 14, 2011
Int'l Isotopes' revenues up 25% in Q3
By AuntMinnie.com staff writers
Increased revenue in its radiochemical products and nuclear medicine standards segments powered radioisotope manufacturer International Isotopes to double-digit growth in the first nine months of 2011.
November 14, 2011
fMRI reveals altered language function in brain tumor patients
By Wayne Forrest
Monday, November 28 | 11:50 a.m.-12:00 p.m. | SSC12-09 | Room N226With the help of functional MRI (fMRI), Swiss researchers have found evidence of how patients can maintain their language function despite a tumor in the corresponding area of the brain.
November 14, 2011
MRI estimates dominant tumor volume for prostate cancer therapy
By Wayne Forrest
Monday, November 28 | 11:30 a.m.-11:40 a.m. | SSC06-07 | Room E353BMRI can accurately estimate the dominant tumor volume and provides greater accuracy in distinguishing tumors larger than 0.5 cm compared with serum prostate-specific antigen and patient age, according to a new study from the U.S. National Cancer Institute.
November 14, 2011
Previous Page
Page 229 of 464
Next Page